探讨EGPA:临床视角对外围阴和肺部参与与现实生活数据的临床观点
Nesrin Ocal1, Deniz Dogan1, Ramazan Ocal2
1Health Sciences University, Gulhane Faculty of Medicine, Department of Pulmonology, Ankara, Turkey.
概括
边缘性埃索诺菲利亚指导肺部疾病的诊断,感染,喘和COPD是常见的. 新的EGPA标准提高了诊断的准确性,减少了严重的eosinophilia病例不必要的测试.
科学领域:
- 肺部病理学 肺部病理学
- 临床医学 临床医学
- 诊断免疫学 诊断免疫学
背景情况:
- 乙氨基酸在急性和慢性肺部疾病中发挥着越来越公认的作用.
- 周围乙素是各种肺部疾病的潜在诊断指标.
研究的目的:
- 为了评估外围氨酸在肺部疾病的诊断实用性.
- 通过使用历史和当前的诊断标准,评估肺病学家对带有多炎 (EGPA) 的埃诺菲尔粒状瘤病的看法.
主要方法:
- 对1567名患有肺部症状和外围好色素的患者进行了回顾性观察队列研究 (2017-2023年).
- 分析患者诊断的情况,埃索诺菲利亚的严重程度,并根据旧的和新的EGPA诊断标准进行审查.
主要成果:
- 肺部感染是最常见的诊断 (1567名患者),其次是喘和COPD.
- 轻度乙素 (90.5%) 是常见的;在恶性瘤,血液学和风湿学疾病 (包括EGPA) 中见到的最高数量.
- 与以前的标准 (92.8%) 相比,目前的EGPA标准显示出较低的假阳性率 (33.3%).
结论:
- 周围叶绿素是肺部疾病的有价值的诊断线索,尽管轻微的升高很常见.
- 准确应用目前的EGPA标准对于准确诊断至关重要,并且避免在严重的eosinophilia病例中进行多余的调查.
相关概念视频
Gastroesophageal Reflux Disease II: Clinical Features and Management
42
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
42
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Asthma: Pathogenesis and Management
298
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
298
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
204
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
204


